| LAST
UPDATED :
Dec 22nd, 2002 - 20:57:51 |
 |
|
SEARCH
|
|
|
|
|
 |
Andropause - Male Menopause
Testosterone therapy was associated with a 95-meter improvement on the shuttle walk test in a double-blind study of 20 heart failure patients, Dr. T. Hugh Jones said at the annual meeting of the Endocrinology Society.
The patients, men with ejection fractions of around 35%, increased their distance walked during the test from an average 280 m to an average 375 m—an increase of 34%—after 12 weeks of testosterone therapy. In contrast, patients who received placebo increased their distance by an average of 2%. Testosterone was given as 100-mg injections delivered once every 2 weeks in the trial.
A larger, confirmatory trial is underway, Dr. Jones of the academic unit of endocrinology at the University of Sheffield (England) said in a press conference.
Low testosterone levels may contribute to exercise intolerance and general fatigue in men with heart failure. Testosterone can promote vasodilatation and may have some beneficial anti-inflammatory properties.
There was no evidence that testosterone increased skeletal muscle strength or bulk, or that it changed plasma levels of proinflammatory cytokines, Dr. Jones said.
© Copyright 2001, All Rights Reserved - Center
For Clinical Age Management, Inc.
Top of Page
|
 |
|
|